These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 23108494)

  • 1. Clinical application of sepsis biomarkers.
    Sankar V; Webster NR
    J Anesth; 2013 Apr; 27(2):269-83. PubMed ID: 23108494
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnostic and prognostic biomarkers of sepsis in critical care.
    Kibe S; Adams K; Barlow G
    J Antimicrob Chemother; 2011 Apr; 66 Suppl 2():ii33-40. PubMed ID: 21398306
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Update on procalcitonin measurements.
    Meisner M
    Ann Lab Med; 2014 Jul; 34(4):263-73. PubMed ID: 24982830
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Procalcitonin-based algorithm. Management of antibiotic therapy in critically ill patients].
    Hochreiter M; Schroeder S
    Anaesthesist; 2011 Jul; 60(7):661-73. PubMed ID: 21660525
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immature platelet fraction in predicting sepsis in critically ill patients.
    De Blasi RA; Cardelli P; Costante A; Sandri M; Mercieri M; Arcioni R
    Intensive Care Med; 2013 Apr; 39(4):636-43. PubMed ID: 23093245
    [TBL] [Abstract][Full Text] [Related]  

  • 6. suPAR as a prognostic biomarker in sepsis.
    Donadello K; Scolletta S; Covajes C; Vincent JL
    BMC Med; 2012 Jan; 10():2. PubMed ID: 22221662
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biomarkers: diagnosis and risk assessment in sepsis.
    Ventetuolo CE; Levy MM
    Clin Chest Med; 2008 Dec; 29(4):591-603, vii. PubMed ID: 18954695
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of thromboelastometry with procalcitonin, interleukin 6, and C-reactive protein as diagnostic tests for severe sepsis in critically ill adults.
    Adamzik M; Eggmann M; Frey UH; Görlinger K; Bröcker-Preuss M; Marggraf G; Saner F; Eggebrecht H; Peters J; Hartmann M
    Crit Care; 2010; 14(5):R178. PubMed ID: 20929576
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Toward an operative diagnosis in sepsis: a latent class approach.
    De La Rosa GD; Valencia ML; Arango CM; Gomez CI; Garcia A; Ospina S; Osorno S; Henao A; Jaimes FA
    BMC Infect Dis; 2008 Feb; 8():18. PubMed ID: 18284667
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The long way of biomarkers: from bench to bedside.
    Zhang H; Damas P; Preiser JC
    Intensive Care Med; 2010 Apr; 36(4):565-6. PubMed ID: 20119646
    [No Abstract]   [Full Text] [Related]  

  • 11. Diagnostic value of procalcitonin, interleukin-6, and interleukin-8 in critically ill patients admitted with suspected sepsis.
    Harbarth S; Holeckova K; Froidevaux C; Pittet D; Ricou B; Grau GE; Vadas L; Pugin J;
    Am J Respir Crit Care Med; 2001 Aug; 164(3):396-402. PubMed ID: 11500339
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interleukin-27 is a novel candidate diagnostic biomarker for bacterial infection in critically ill children.
    Wong HR; Cvijanovich NZ; Hall M; Allen GL; Thomas NJ; Freishtat RJ; Anas N; Meyer K; Checchia PA; Lin R; Bigham MT; Sen A; Nowak J; Quasney M; Henricksen JW; Chopra A; Banschbach S; Beckman E; Harmon K; Lahni P; Shanley TP
    Crit Care; 2012 Oct; 16(5):R213. PubMed ID: 23107287
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Eosinopenia: Is it a good marker of sepsis in comparison to procalcitonin and C-reactive protein levels for patients admitted to a critical care unit in an urban hospital?
    Shaaban H; Daniel S; Sison R; Slim J; Perez G
    J Crit Care; 2010 Dec; 25(4):570-5. PubMed ID: 20435431
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The utility of proadrenomedullin and procalcitonin in comparison to C-reactive protein as predictors of sepsis and bloodstream infections in critically ill patients with cancer*.
    Debiane L; Hachem RY; Al Wohoush I; Shomali W; Bahu RR; Jiang Y; Chaftari AM; Jabbour J; Al Shuaibi M; Hanania A; Pravinkumar SE; Schuetz P; Raad I
    Crit Care Med; 2014 Dec; 42(12):2500-7. PubMed ID: 25083975
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The efficacy of procalcitonin as a biomarker in the management of sepsis: slaying dragons or tilting at windmills?
    Sridharan P; Chamberlain RS
    Surg Infect (Larchmt); 2013 Dec; 14(6):489-511. PubMed ID: 24274059
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biomarkers in the critically ill patient: procalcitonin.
    Reinhart K; Meisner M
    Crit Care Clin; 2011 Apr; 27(2):253-63. PubMed ID: 21440200
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combination biomarkers to diagnose sepsis in the critically ill patient.
    Gibot S; Béné MC; Noel R; Massin F; Guy J; Cravoisy A; Barraud D; De Carvalho Bittencourt M; Quenot JP; Bollaert PE; Faure G; Charles PE
    Am J Respir Crit Care Med; 2012 Jul; 186(1):65-71. PubMed ID: 22538802
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Procalcitonin as a diagnostic test for sepsis in critically ill adults and after surgery or trauma: a systematic review and meta-analysis.
    Uzzan B; Cohen R; Nicolas P; Cucherat M; Perret GY
    Crit Care Med; 2006 Jul; 34(7):1996-2003. PubMed ID: 16715031
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Procalcitonin: potential role in diagnosis and management of sepsis.
    Rowland T; Hilliard H; Barlow G
    Adv Clin Chem; 2015; 68():71-86. PubMed ID: 25858869
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rapid diagnostic methods in the detection of sepsis.
    Carlet J
    Infect Dis Clin North Am; 1999 Jun; 13(2):483-94, xi. PubMed ID: 10340179
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.